U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
cosfroviximab [INN]
Preferred Name English
COSFROVIXIMAB
INN   USAN  
USAN   INN  
Official Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(EBOLAVIRUS/RESTON EBOLAVIRUS/SUDAN EBOLAVIRUS/TAI FOREST EBOLAVIRUS GLYCOPROTEIN)CHIMERIC HOMO SAPIENS-MUS MUSCULUS MONOCLONAL ANTIBODY: .GAMMA.1 HEAVY CHAIN (1-452) (MUS MUSCULUS VH (IGHV8-8*01 (77%) (IGHD)-IGHJ4*01 (93%))
Systematic Name English
ZMAPP COMPONENT C13C6FR1
Common Name English
13C6
Code English
C13C6FR1
Code English
COSFROVIXIMAB [USAN]
Common Name English
Cosfroviximab [WHO-DD]
Common Name English
ZMAPP COMPONENT C13C6
Brand Name English
ZMAPP COMPONENT C13C6-FR1
Common Name English
C13C6-FR1
Code English
MB-003 COMPONENT C13C6-FR1
Common Name English
IMMUNOGLOBULIN G1, ANTI-(EBOLAVIRUS/RESTON EBOLAVIRUS/SUDAN EBOLAVIRUS/TAI FOREST EBOLAVIRUS GLYCOPROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL C13C6-FR1 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL C13C6-FR1 .KAPPA.-CHAIN, DIMER
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 440914
Created by admin on Tue Apr 01 16:24:42 GMT 2025 , Edited by admin on Tue Apr 01 16:24:42 GMT 2025
Code System Code Type Description
FDA UNII
820CI2BHRP
Created by admin on Tue Apr 01 16:24:42 GMT 2025 , Edited by admin on Tue Apr 01 16:24:42 GMT 2025
PRIMARY
CAS
1792982-57-0
Created by admin on Tue Apr 01 16:24:42 GMT 2025 , Edited by admin on Tue Apr 01 16:24:42 GMT 2025
PRIMARY
SMS_ID
300000005740
Created by admin on Tue Apr 01 16:24:42 GMT 2025 , Edited by admin on Tue Apr 01 16:24:42 GMT 2025
PRIMARY
NCI_THESAURUS
C171831
Created by admin on Tue Apr 01 16:24:42 GMT 2025 , Edited by admin on Tue Apr 01 16:24:42 GMT 2025
PRIMARY
USAN
DE-19
Created by admin on Tue Apr 01 16:24:42 GMT 2025 , Edited by admin on Tue Apr 01 16:24:42 GMT 2025
PRIMARY
INN
10535
Created by admin on Tue Apr 01 16:24:42 GMT 2025 , Edited by admin on Tue Apr 01 16:24:42 GMT 2025
PRIMARY
ACTIVE MOIETY
COSFROVIXIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966